Page 22 - 74_02

MERITXELL NUS Y COLS. AN. R. ACAD. NAC. FARM.

(12) paraoxonase/arylesterase activity in diabetic postmenopausal women. Meta-
(13) bolism. 50: 319-324.
(14) ECKERSON, H. W.; ROMSON, J.; WYTE, C. and LA DU, B. N. (1983): The human
serum paraoxonase/arylesterase polymorphism. Am. J. Human Genet. 35:
(15) 214-227.
(16) BELTOWSKY, J.; GRAZYNA, W. and MARCINIAK, A. (2002): Species and substrate-
(17) specific stimulation of human plasma paraoxonase 1 (PON1) activity by high
(18) chloride concentration. Acta Biochim. Pol. 49: 927-936.
(19) REINER, E.; SVEDRUZIC, D.; SIMEON-RUDOLF, V.; LIPOVAC, V.; GAVELLA, M. and
(20) MRZLJAK, V. (1999): Paraoxonase end arylesterase activities in the serum of
(21) two hyperlipoproteinaemic patients alter repeated extracorporal lipid preci-
(22) pitation. Chem-Biol. Interac. 120: 405-411.
(23) LIAO, F.; LIU, W. L.; ZHOU, Q. X.; ZENG, Z. C. and ZUO, Y. P. (2001): Assay of
(24) serum arylesterase activity by fitting to the reaction curve with an integrated
(25) rate equation. Clin. Chim. Acta. 314: 67-76.
(26) BUTTE, W. and KEMPER, K. (1999): A spectrophotometric assay for pyrethroid-
(27) cleaving enzymes in human serum. Toxicol. Lett. 107: 49-53.
LORENTZ, K.; WIRTZ, W. and WEIß, T. (2001): Continuous monitoring aryles-
terase in human serum. Clin. Chim. Acta. 308: 69-78.
BUTTE, W. and KEMPER, K. (1999): A spectrophotometric assay for pyrethroid-
cleaving enzymes in human serum. Toxicol. Lett. 107: 49-53.
DEBORD, J.; BOLLINGER, J. C.; MERLE, L. and DANTOINE, T. (2003): Inhibition of
human serum arylesterase by metal chlorides. J. Inorg. Chem. 94: 1-4.
DEBORD, J.; BOLLINGER, J. C.; ABRAHAM, M. H.; MERLE, L. and DANTOINE, T.
(2002): Inhibition of arylesterase by organic solvents: Structure-activity rela-
tionships. Internet J. Chem. 5: 4.
DEBORD, J.; DANTOINE, T.; BOLLINGER, J. C.; ABRAHAM, M. H.; VERNEUIL, B. and
MERLE, L. (1998): Inhibition of arylesterase by aliphatic alcohols. Chem-Biol.
Interact. 113: 105-115.
DEBORD, J.; HAREL, M.; BOLLINGER, J. C.; VERNEUIL, B.; MERLE, L. and DANTOINE,
T. (2005): Flow microcalorimetric study of enzyme reactions. Application to
arylesterase from human serum. Thermochimica Acta. 427: 85-91.
KOKUBO, T.; KUSHITANI, H. and SAKKA, S. (1990): Solutions able to reproduce
in vivosurface structure changes in bioactive glass-ceramic A-W. J. Biomed.
Mat. Res. 24: 721-734.
TAKADAMA, A.; HASHIMOTO, H.; MIZUNO, M.; ISHIKAWA, K. and KOKUBO, T. (2004):
Newly improved simulated body fluid. Key Engin. Mat. 255: 115-118.
OYANE, A.; ONUMA, K.; ITO, A.; KIM, H. M.; KOKUBO, T. and NAKAMURA, T. (2003):
Formation and growth of clusters in conventional and new kinds of simula-
ted body fluids. J. Biomed. Mat. Res. 64: 339-348.
NUS, M.; SÁNCHEZ-MUNIZ, F. J. and SÁNCHEZ-MONTERO, J. M. (2006): A new
method for the determination of arylesterase activity in human serum using
Simulated Body Fluid. Atherosclerosis. 188: 155-159.
NUS, M.; SÁNCHEZ-MUNIZ, F. J. and SÁNCHEZ-MONTERO, J. M. (2006): Determina-
ción de la actividad arilesterasa en ratones utilizando un mimético de suero.
BioSpain, BIOTEC 2006. Madrid (Comunicación oral).

200